SEC Form 4 · accession 0001209191-16-139196
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
James T Lafrance
Director
Period of report
Aug 26, 2016
Accepted (ET)
Aug 30, 2016 · 6:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.46 | Aug 26, 2016 | A | 5,000 | A | — | Aug 25, 2026 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1One-third of the shares will vest on December 1, 2016 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on the third anniversary of August 26, 2016.